Biological Significance of Local TGF-β Activation in Liver Diseases

Abstract

The cytokine transforming growth factor-β (TGF-β) plays a pivotal role in a diverse range of cellular responses, including cell proliferation, apoptosis, differentiation, migration, adhesion, angiogenesis, stimulation of extracellular matrix (ECM) synthesis, and downregulation of ECM degradation. TGF-β and its receptors are ubiquitously expressed by most cell types and tissues in vivo. In intact adult tissues and organs, TGF-β is secreted in a biologically inactive (latent) form associated in a non-covalent complex with the ECM. In response to injury, local latent TGF-β complexes are converted into active TGF-β according to a tissue- and injury type-specific activation mechanism. Such a well and tightly orchestrated regulation in TGF-β activity enables an immediate, highly localized response to type-specific tissue injury. In the pathological process of liver fibrosis, TGF-β plays as a master profibrogenic cytokine in promoting activation and myofibroblastic differentiation of hepatic stellate cells, a central event in liver fibrogenesis. Continuous and/or persistent TGF-β signaling induces sustained production of ECM components and of tissue inhibitor of metalloproteinase synthesis. Therefore, the regulation of locally activated TGF-β levels is increasingly recognized as a therapeutic target for liver fibrogenesis. This review summarizes our present knowledge of the activation mechanisms and bioavailability of latent TGF-β in biological and pathological processes in the liver.

Osteogenic Differentiation Evaluation of an Engineered Extracellular Matrix Based Tissue Sheet for Potential Periosteum Replacement

“…Second, there are many active binding sites in ECM secreted by cells for entrapment of various growth factors and calcium. For example, ECM component heparin sulfate proteoglycans have specific binding for bFGF, fibronectin specifically binds TGF-β26,27 . These growth factors play important roles in major…”

Review article: the prevention and reversal of hepatic fibrosis in autoimmune hepatitis

“…Cytokines, including transforming growth factor-beta 1 (TGFb1), platelet-derived growth factor (PDGF) and endothelial growth factor (EGF) induce the activated hepatic stellate cells to transform into myofibroblasts, [112][113][114][115] and interventions that inhibit the production of these cytokines may limit this transformation and reduce collagen production. Similarly, angiotensin II is secreted by hepatic stellate cells, and it induces their proliferation and the production of extracellular matrix.…”

Hepatitis B virus X protein activates human hepatic stellate cells through upregulating TGFβ1

“…This activated TβRI kinase phosphorylates Smad2 or Smad3, which subsequently form a complex with Smad4 and migrate to the nucleus to regulate expression of target genes, including collagens (Bauer and Schuppan, 2001;Zong et al, 2012). In the process of hepatic fibrosis, TGFβ is the main mediator of fibrogenesis, which can promote activation of HSCs and induce sustained production of ECM components (Friedman, 2000;Pinzani and Marra, 2001;Bataller and Brenner, 2005;Moreira, 2007;Hayashi and Sakai, 2012). Our study confirmed that HBx protein upregulated the mRNA and protein expression of TGFβ1 in HSCs, leading to activation of HSCs and increased expression of Col I (Kisseleva and Brenner, 2007).…”